BeStock  
Stocks › Biotechnology › CRSP

CRISPR Therapeutics CRSP

$39.10 +$0.17 (+0.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.50 +1.02%
Open$38.18
Prev close$38.93
Day range$38.15 – $40.17
Volume3.32M
Market cap$3.79B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership81.1%-0.86 pts vs. prior quarter
Institutions holding612+2 vs. prior quarter
Insider trades (recent)34 buys / 13 sellsNet buying
ARK fund activity+43,887 sh1 recent transactions · last 11 Oct 2026
Short interest17.78% of floatDays to cover 13.1 · as of 30 Oct 2026
Short-sale volume share32.1%5-day average of daily volume

Short-sale volume as % of daily volume

11%21%31%41%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$21.27M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$5.4MSuper−$15.8MBig−$5.8MMid+$934.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.1% of shares outstanding.

Largest holders

  • ARK Investment Management LLC10.37%
  • BlackRock8.56%
  • Capital Research6.41%
  • Orbis Investment Management Limited5.62%
  • State Street Global Advisors5.15%
  • GSK Equity Investments, Limited2.69%
  • Geode Capital Management, LLC2.59%
  • T. Rowe Price Group, Inc.2.25%

By investor type

  • Mutual Fund61.26%
  • Hedge Fund6.62%
  • VC/PE Fund6.05%
  • Public Company2.95%
  • Private Company1.95%
  • Government Pension Fund1.51%
  • Individual/Insider0.52%
  • Sovereign Wealth Fund0.30%

Reported short interest has fallen from 19.39% to 17.78% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Carne Global Fund Managers Ireland Limited Mutual Fund 2026/Q3 +49,020 0.1%
Samarth Kulkarni Individual/Insider 2026/Q3 +56,398 0.3%
State Street Global Advisors Mutual Fund 2026/Q3 +672,381 5.1%
ARK Investment Management LLC Mutual Fund 2026/Q3 +595,905 10.4%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +136,379 0.2%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +65,335 0.1%
NTV Asset Management, LLC Mutual Fund 2026/Q3 +61,443 0.1%
Barclays PLC Public Company 2026/Q3 +46,168 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +79,519 0.2%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +893,812 0.9%
BlackRock Mutual Fund 2026/Q3 +668,904 8.6%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +505,570 2.1%
State Street Global Advisors Mutual Fund 2026/Q3 +339,166 4.5%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +300,000 0.3%
Morgan Stanley Public Company 2026/Q3 +185,927 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Nov 2026 Raju Prasad Officer Intent to Sell (Form 144) -79,393 $49.88 –
3 Nov 2026 Sivakesava Sakhamuri Chief Technology Officer Other Derivative Acquisition +40,000 – 40,000
3 Nov 2026 Sivakesava Sakhamuri Chief Technology Officer Other Derivative Acquisition +90,000 $51.78 90,000
25 Oct 2026 Samarth Kulkarni Chairperson & CEO Other Derivative Acquisition +28,750 – 28,750
25 Oct 2026 Samarth Kulkarni Chairperson & CEO Other Derivative Acquisition +57,500 $49.01 57,500
25 Oct 2026 Naimish Patel Chief Medical Officer Other Derivative Acquisition +12,000 – 12,000
25 Oct 2026 Naimish Patel Chief Medical Officer Other Derivative Acquisition +24,000 $49.01 24,000
25 Oct 2026 James Kasinger General Counsel Other Derivative Acquisition +9,000 – 9,000
25 Oct 2026 James Kasinger General Counsel Other Derivative Acquisition +18,000 $49.01 18,000
25 Oct 2026 Andrew Silver CFO, Principal Financial Officer & Principal Accounting Officer Other Derivative Acquisition +9,000 – 9,000
25 Oct 2026 Andrew Silver CFO, Principal Financial Officer & Principal Accounting Officer Other Derivative Acquisition +18,000 $49.01 18,000
18 Oct 2026 Andrew Silver CFO, Principal Financial Officer & Principal Accounting Officer Other Derivative Acquisition +25,000 – 25,000
18 Oct 2026 Andrew Silver CFO, Principal Financial Officer & Principal Accounting Officer Initial Statement of Beneficial +0 – 85,374
18 Oct 2026 Samarth Kulkarni Chairperson & CEO Derivative Exercise and Sale -47,837 $49.78 311,899
15 Oct 2026 Samarth Kulkarni Chairperson & CEO Derivative Exercise and Retained +52,163 – 311,899
13 Oct 2026 Simeon George Independent Director Derivative Exercise and Sale -14,514 $49.63 15,486
13 Oct 2026 Simeon George Independent Director Derivative Exercise and Retained +15,486 $14.00 15,486
13 Oct 2026 Samarth Kulkarni Chairperson & CEO Derivative Exercise and Sale -4,098 $49.26 259,736
13 Oct 2026 James Kasinger General Counsel Derivative Exercise and Sale -1,040 $49.26 95,857
12 Oct 2026 Samarth Kulkarni Chairperson & CEO Derivative Exercise and Retained +4,235 – 259,736

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 17,189,067 17.8% 13.1
15 Oct 2026 16,442,415 17.0% 10.2
30 Sep 2026 18,679,198 19.3% 9.6
15 Sep 2026 19,071,093 19.7% 16.5
31 Aug 2026 18,769,995 19.4% 10.7
14 Aug 2026 18,744,855 19.4% 15.6

Discussion

No comments yet — be the first to weigh in on CRSP.

Sign in to join the discussion.

Scroll to Top